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 26 
Abstract 27 
Phocid herpesvirus 1 (PhHV-1) is known to infect grey seals (Halichoerus grypus) but little 28 
is known about its pathogenicity or true prevalence in this species. To investigate the 29 
prevalence of and risk factors associated with PHV-1 infection, nasal swabs were collected 30 
from grey seal pups and yearlings on the Isle of May, a well-studied grey seal breeding 31 
colony, and from stranded grey seal pups submitted to a rehabilitation centre. Phocid herpes 32 
virus 1 nucleic acids were detected in nasal swabs from 58% (52/90) of live, free-ranging 33 
grey seal pups, 62% (18/29) of live, stranded grey seal pups and 28% (5/18) live free-ranging 34 
yearlings suggesting recrudescence in the latter. Location within the colony, pup body mass 35 
and stranding were determined to be risk factors for shedding PhHV-1 in live seal pups with a 36 
significantly higher prevalence of PhHV-1 in pups born on the tidal boulder beach when 37 
compared to other sites; a significantly positive correlation of PhHV-1 shedding and pup 38 
body mass and a higher prevalence in stranded grey seal pups compared to their free-ranging 39 
conspecifics. The prevalence of PhHV1 in dead pups on the Isle of May was 56% (27/48) 40 
with a positive PhHV-1 PCR status significantly associated with hepatic necrosis (p=0.01), 41 
thymic atrophy (p<0.001) and buccal ulceration (p=0.027). Results indicate that PhHV-1 was 42 
widespread in the pups in the Isle of May grey seal breeding colony.  43 
 44 
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Introduction 51 
Phocid herpesvirus-1 (PhHV-1) is an alphaherpesvirus which infects both grey (Halichoerus 52 
grypus) and harbour (Phoca vitulina) seals in the Eastern Atlantic and Pacific Oceans (Borst 53 
et al. 1986, Harder et al. 1996, Gulland et al. 1997, Martina et al. 2002, Himworth et al. 54 
2010). The alphaherpesvirus subfamily consists of large double-stranded DNA viruses of 55 
variably narrow to broad host range, typically characterised by rapid replication in cell 56 
culture, lytic infection and the ability to develop latent infections in sites such as the 57 
trigeminal ganglia (Caswell & Williams 2007). Alphaherpesviruses are responsible for a 58 
number of economically important diseases in domestic species including Bovine herpesvirus 59 
1 (BoHV-1) which causes infectious bovine rhinotracheitis in calves and abortion in cows, 60 
Suid herpesvirus which causes Aujeszky’s disease and abortion in pigs and Equid 61 
herpesviruses 1 and 4 which result in respiratory and neurological diseases in horses. Another 62 
feature of many alphaherpesviruses is the ability to induce immunosuppression (Winkler et 63 
al. 1999, Brukman & Enquist 2006, Van de Walle et al. 2008). 64 
 65 
Infection of harbour seals by PhHV-1 and the resultant disease has been well documented as 66 
the pathology and pathogenesis of this virus differs between geographically distinct 67 
populations. Eastern Atlantic harbour seals develop hepatic necrosis, interstitial pneumonia, 68 
renal tubular epithelial degeneration, oral mucosal ulceration and lymphodepletion (Borst et 69 
al. 1986), whereas Pacific harbour seals develop adrenocortical necrosis and multifocal 70 
hepatic necrosis with intranuclear viral inclusion bodies (Gulland et al. 1997). Morbidity and 71 
mortality due to PhHV-1 vary from high (Osterhaus et al. 1985, Gulland et al. 1997) to low 72 
(Goldstein et al. 2004) suggesting that extrinsic factors, such as stress or concurrent disease, 73 
may affect the severity of the clinical manifestation of the disease in harbour seals (Goldstein 74 
et al. 2004). However, very little is known about the pathogenicity and epidemiology of 75 
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PhHV-1 infection in grey seals. Grey seals develop less severe clinical signs upon PhHV-1 76 
infection than harbour seal pups when in rehabilitation centres (Martina et al. 2002).  In 77 
Harbour seals, the virus causes moderate to severe clinical respiratory disease in younger 78 
pups, with more mild disease and correspondingly less severe clinical signs to sub-clinical 79 
infections in older animals (Martina et al. 2002).  80 
 81 
“Stranded” seal pups are assumed to be stressed and are frequently malnourished, both 82 
factors known to impair immune function (Snyder 2007) and this would result in pups being 83 
more susceptible to infection and prolong shedding. Consequently, we hypothesise that the 84 
prevalence of known enzootic grey seal pathogens, such as PhHV-1, is likely to be higher in 85 
stranded seal pups than in seal pups from their natal colonies and higher in dead seal pups 86 
compared to live pups.  87 
 88 
The aims of this study were to assess the prevalence and risk factors for PhHV-1 infection in 89 
live free-ranging and stranded grey seal pups and in yearlings. Within a breeding colony, the 90 
effect of location within the colony (ground substrate and animal movements), time of birth 91 
during the pupping season and host factors such as body mass and age were investigated as 92 
risk factors for the presence of PhHV-1. In addition, the prevalence and pathology associated 93 
with PhHV-1 infection were investigated in dead grey seal pups both on their natal colony 94 
and in a rehabilitation centre. 95 
 96 
  97 
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Materials and methods 98 
Animals and sampling 99 
Grey seal pups and yearlings were sampled during the pupping season of autumn 2011. Free-100 
ranging, live (n=90) and dead (n=50) grey seal pups and live yearlings (n=19) were sampled 101 
on the Isle of May (IOM), Firth of Forth, UK. Live grey seal pups were sampled from three 102 
distinct sites on the Isle of May which had different substrate and animal movement 103 
characteristics (tidal boulder beach with twice daily congregations of pups due to 104 
displacement by the tide (n=30); muddy/grassy slope with sedentary pups (n=30) and 105 
stagnant rocky pools with sedentary pups (n=30)) and at three different time points (early, 106 
mid and late pupping season). Dead grey seal pups were collected opportunistically 107 
throughout the season from varied sites on the colony and within 48h of death. Additionally, 108 
live-stranded grey seal pups (n=31) were sampled within 24h of arrival at the Scottish 109 
Society for the Prevention of Cruelty to Animals National Wildlife Centre (SSPCA), Fife as 110 
part of the routine health assessment procedure to determine suitability for care and 111 
rehabilitation prior to release back into the wild. All sampling of live animals on the Isle of 112 
May was carried out under UK Home Office Project (No. 60/4009) and Personal Licences as 113 
issued to the Sea Mammal Research Unit under the Animals (Scientific Procedures) Act, 114 
1986. All sampling of live animals submitted to the rehabilitation centre was for diagnostic 115 
purposes to determine the cause of stranding and future treatment regime. 116 
In addition, stranded pups at the SSPCA rehabilitation centre that subsequently died or were 117 
euthanised on humane grounds (n=9) were sampled also as part of this study. 118 
The following data were recorded: sex, pup developmental stage (stage I to stage V) as 119 
described by Kovacs and Lavigne (1986), body mass (to the nearest 100g) using spring 120 
balanced scales (Salter Industrial Measurements Ltd., West Bromwich, UK) in a pup-bag; 121 
length (nose to tail, to the nearest 5mm), girth immediately posterior to the axilla (to the 122 
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nearest 5mm) and the presence of any external anomalies (bites, areas of alopecia, nasal 123 
discharge, ocular discharge, presence/absence of umbilical cord).  124 
 125 
A nasal swab was obtained from all live and dead animals examined, using a nylon flocked 126 
swab and placed into universal transport medium (UTM) (swab and UTM: Catalogue no. 127 
346C, Sterilin, Newport, UK). Swabs were initially stored at 4°C and subsequently frozen at -128 
80°C within 12 hours of collection until analysis. A full post-mortem examination was 129 
performed on all dead pups and samples collected for histopathology. Pooled representative 130 
samples of 10 organs (liver, spleen, mesenteric lymph node, ileo-caeco-colic junction, 131 
kidney, left cranial lung lobe, bronchial lymph node, right ventricle, tonsil and brain) were 132 
collected aseptically, placed in a sterile gentleMACS™ M tube (Miltenyi Biotec, Bisley, UK) 133 
and frozen at -80°C until analysis. 134 
 135 
Sample processing and analysis 136 
Nasal swabs in universal transport medium were placed into a sonicator bath for 30s and then 137 
centrifuged at 2000g for 10min at 4°C. The resultant supernatant was stored at -80°C until 138 
analysis. Pooled tissue samples were homogenised with 5ml viral transport medium using a 139 
Dispomix homogeniser (Miltenyi Biotec Ltd., Bisley, UK), centrifuged at 2000g for 10min at 140 
4°C and the resultant supernatant stored at -80°C until analysis. Nucleic acids were extracted 141 
from supernatants using the NorDiagViral NA Arrow automated extraction robot (Alere, 142 
Stockport, UK) as per manufacturer’s instructions and stored at -20°C. Extraction controls 143 
(water or PBS) were processed with every batch of tissue and swab samples.  144 
 145 
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Detection of PhHV-1 specific nucleic acids 146 
Nucleic acids extracted from the nasal swabs and pooled tissue samples were assessed for the 147 
presence of PhHV-1 nucleic acids using an end-point PCR assay amplifying a 450bp 148 
fragment of the PhHV-1 specific glycoprotein B (gB) gene as described previously 149 
(Goldstein et al. 2004). DNA extraction controls, positive and negative (no template DNA) 150 
controls were included for all reactions. Positive control material consisted of grey seal liver, 151 
previously found positive for PhHV-1 following pan-Herpesvirus nested degenerate PCR 152 
(Ehlers et al. 1999) and subsequent direct sequencing of the product (Eurofins MWG, 153 
Ebersberg, Germany). Reactions were performed in a total volume of 50 μl, using Platinum 154 
Taq (Invitrogen, Paisley, UK) and containing a final concentration of 200 μM of each primer 155 
and 2 μl of template DNA. Reactions were performed in a Techne Workbench thermal cycler 156 
(Techne, Stone, UK) with the following cycling parameters: 95°C for 3 min 157 
(denaturation/Taq activation) followed by 35 cycles of denaturation for one minute at 94°C, 158 
annealing for one minute at 60°C and extension for one minute at 72°C with a final extension 159 
at 72°C for 10 min. Reaction products were electrophoresed on a 1.5% agarose gel, stained 160 
with Sybrsafe (Invitrogen) and visualised by UV transillumination using a gel doc system 161 
(Alpha Imager, San Leandro, CA). A reverse transcriptase real-time PCR (RT-qPCR) assay 162 
amplifying the stable housekeeping gene beta-actin was used in a separate assay to assess 163 
sample integrity as described by Thonur et al. (2012).  164 
 165 
Histopathology and immunohistochemistry 166 
Samples from 59 pups (50 from IOM and 9 from SSPCA) were fixed in 10% neutral buffered 167 
formalin, processed routinely and embedded in paraffin wax for histopathological 168 
examination by a boarded veterinary pathologist. After review of histopathological findings, 169 
the degree of thymic atrophy (as a proxy for immunosuppression) was assessed using a 170 
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subjective scoring system ranging from 0 to 3 (none, mild, moderate and severe respectively). 171 
The adrenal cortico-medullary ratio was measured (AnalySIS Five software, Soft Imaging 172 
System GmbH, Münster, Germany). A cause of death was assigned to each animal by a 173 
boarded veterinary pathologist following gross post mortem, detailed histopathological 174 
examination and routine bacteriology examination.  175 
 176 
An attempt at immunohistochemical localisation of PhHV-1 within microscopical lesions was 177 
made in the present study using antibodies directed against both BoHV-1 and FeHV-1  in 178 
separate assays (Baily 2014), and no cross-reactivity of PhHV-1 was detected with these 179 
antibodies on control tissue slides (harbour seal infected with PhHV1). Briefly, endogenous 180 
peroxidase activity was blocked by immersion in 3% H2O2 in methanol (vol/vol) for 20 min. 181 
Tissues were incubated with 150 μl of 25% normal goat serum (NGS; Vector) in PBS-0.05% 182 
Tween 20 (PBST) for an hour at room temperature to block non-specific antibody binding. 183 
Primary antibodies were Bovine herpesvirus 1 (clone F2; mouse monoclonal IgG2b 184 
(Veterinary Medical Research and Development, Pullman, WA, USA), dilution 1:5000; 185 
incubated overnight at 4C), and feline herpesvirus 1 (Clone FHV5; mouse monoclonal 186 
IgG2b (Acris antibodies, Herford, Germany), dilution 1:100, incubated 30 minutes at room 187 
temperature). Visualisation of the primary antibody was by Envison™ anti-mouse HRP 188 
polymer (Vector Laboratories etc.) as per manufacturer’s protocols. Positive control material 189 
consisted of bovine liver infected with BoHV1 and feline lung infected with FHV1 190 
respectively and showed immunolabelling within lesions.  191 
 192 
Statistical analyses 193 
Prevalence data were analysed using the R statistical software package (R Core Team 2013). 194 
To investigate significant differences in prevalence of PhHV-1 in nasal swabs between 195 
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groups Fisher’s exact tests were performed. For univariate analysis generalized linear models 196 
(GLMs) with a binomial distribution family and a logit link function was used to evaluate the 197 
effects of different morphologic measurements (standard length, body mass, axillary girth), 198 
age (stage of pup development as a proxy), sex, sampling time, colony (stranded versus free-199 
ranging animals) and ground substrate on the presence or absence of PhHV-1. Multivariate 200 
logistic regression was performed using R with a forward stepping algorithm and a p value of 201 
≤0.05 for inclusion in the model based on the likelihood ratio test. Any stranded grey seal 202 
pups which died at the rehabilitation centre were excluded from the multivariate analysis of 203 
PhHV-1 nasal swab status to avoid repeat sampling of the individual animals swabbed on 204 
entry to the rehabilitation centre. As length, body mass, girth and pup stage were highly 205 
correlated with each other, and so as not to violate the assumption in generalised linear 206 
models concerning the independence of independent variables, body mass was chosen as the 207 
most reliable, independently verified and reproducible of the morphometric measurements in 208 
the present study and retained for further analyses. Akaike’s Information Criterion (AIC) was 209 
used to compare models and choose the most parsimonious for each variable. Residual 210 
analysis was used to assess goodness of fit.  211 
 212 
Results 213 
Prevalence of PhHV-1 in grey seal pups and yearlings 214 
The prevalence of PhHV-1 in nasal swabs of all pups was 59.6% (105/176) with a prevalence 215 
of 62% (18/29) in stranded, live pups presented for rehabilitation, 57.8% (52/90) in free-216 
ranging live pups on the IOM colony and 56.3% (27/48) dead pups on the IOM colony. The 217 
group with the highest prevalence was the stranded dead pup group with a prevalence of 89% 218 
(8/9, Table 1). Yearlings had a significantly lower prevalence of PhHV-1 (28%) than pups 219 
(60%) (p=0.008; Fisher’s exact test). 220 
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 221 
Odds ratios for categorical risk factors were determined for PhHV-1 (Table S 1). Live and 222 
dead free-ranging pups sampled in the late pupping season had significantly higher odds of 223 
being PhHV-1 positive in nasal swabs, as determined by presence of PhHV-1 nucleic acids, 224 
than pups sampled in the early pupping season (p<0.001, GLM). Also, free-ranging pups 225 
sampled at stage I (youngest age sampled) were significantly less likely to be shedding 226 
PhHV-1 in nasal secretions compared to pups in any of stages III, IV and V (p=0.004; 227 
p=0.002; p=0.024, respectively). 228 
 229 
For live, free-ranging pups, the final logistic regression model demonstrated that an increased 230 
risk for PhHV-1 nasal shedding was associated with the location on the colony, as well as 231 
with the body mass of the pup at the time of sampling (Table S 2). Seals born around the 232 
rocky pools (OR=0.55, 95% CI 0.18, 1.62, p=0.015) and on the grassy, muddy slope 233 
(OR=0.24, 95% CI 0.08, 0.72, p=0.002) were significantly less likely to be positive for 234 
PhHV-1 in nasal swabs than pups born on the tidal boulder beach. The odds of shedding 235 
PhHV-1 were increased by a factor 1.15 for every extra kg of pup body mass and an increase 236 
in pup body mass from 10kg to 20kg results in an increase in odds of 3.91of having PhHV-1 237 
specific DNA on the nasal mucosal membrane.  238 
 239 
When considering all live pups (stranded and free-ranging), stepwise logistic regression 240 
analysis indicated that, among the variables examined, body mass and colony (stranded 241 
versus free-ranging animals) were statistically significant multivariate predictors of positive 242 
PhHV-1 PCR result from nasal swabs. The final logistic regression for PhHV-1 nasal swab 243 
PCR status is presented in Table S 3. No correlation of PhHV-1 with body mass, length or 244 
girth was found in the samples from yearlings.  245 
11 
 
 246 
Tissue samples  247 
The presence of PhHV-1 DNA in nasal swabs correlated significantly with the presence of 248 
PhHV-1 DNA in pooled tissue samples (p=0.005). No significant difference was noted 249 
between the prevalence of PhHV-1 in tissues of dead free-ranging pups on the IOM when 250 
compared to dead stranded pups at the SSPCA.  251 
 252 
Pathology 253 
To investigate the relationship between PhHV-1 and the presence of specific lesions in dead 254 
pups, those with a positive result in either a nasal swab or pooled tissue sample were 255 
considered positive for PhHV-1. A positive PhHV-1 PCR result was significantly associated 256 
with the presence of hepatic necrosis (FET, p=0.01), thymic atrophy (FET, p<0.001) and 257 
buccal ulceration (FET, p=0.027) (Table S 4). The degree of thymic atrophy was significantly 258 
associated with the PhHV-1 status of the pups examined with a higher prevalence of PhHV-1 259 
in pups with moderate to severe thymic atrophy (Figure 1). In addition, the presence of 260 
thymic atrophy was positively correlated with adrenal cortico-medullary ratio (p=0.006). A 261 
single pup presented intranuclear inclusion bodies within hepatocytes in proximity to foci of 262 
necrosis. No inclusion bodies were noted in the adrenal glands of any pups examined. There 263 
was no relationship between PhHV-1 infection and interstitial pneumonia or encephalitis. 264 
265 
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  266 
Discussion 267 
This is the first study of the prevalence of PhHV-1 in live and dead grey seal pups on a 268 
specific breeding colony. The widespread presence of PhHV-1 in live and dead grey seal 269 
pups (56.3% and 57.8% in dead and live free-ranging grey seal pups, respectively) shows that 270 
this virus is widespread on the Isle of May breeding colony and suggests that most pups will 271 
have been exposed to this virus by the time they leave the island (at approximately 6 weeks 272 
of age). This finding is typical of host-adapted alpha herpesviruses in densely populated 273 
breeding colonies, such as is seen in breeding catteries with felid herpesvirus 1 (FeHV-1) and 274 
breeding kennels with canid herpesvirus 1 (CaHV-1) (Gaskell & Willoughby 1999, Gaskell 275 
et al. 2007) and is comparable to the high prevalence of PhHV-1 (40%) in nasal swabs 276 
recorded in live, free-ranging pre- and post-weaned harbour seal pups in California 277 
(Goldstein et al. 2004) and 91 to 93% seroprevalence of PhHV-1 in adult grey seals (Roth et 278 
al. 2013).  279 
 280 
The strong correlation between PhHV-1 DNA in nasal swabs and increased pup body mass, 281 
itself confounded with age, suggests horizontal transmission within the colony. None of the 282 
stillborn pups (n=5) were positive for PhHV-1, but the small sample size prohibits further 283 
interpretation regarding whether vertical transmission occurs. In other animal species infected 284 
with alphaherpesviruses, such as CaHV-1and FeHV-1, transmission often occurs at or around 285 
parturition, with recrudescence of the virus in maternal tissues and transmission to the 286 
neonate via vaginal secretions or nasal shedding (Gaskell & Willoughby 1999, Schlafer & 287 
Miller 2007). Goldstein et al. (2004) showed that viral shedding in nasal secretions of 288 
stranded harbour seal pups occurred 4–7 days post direct contact exposure. These findings 289 
could explain the low prevalence of nasal shedding in early stage pups in the present study. 290 
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Indeed, a negative PCR result in nasal swabs in early stage pups would not rule out the 291 
possibility of peri-natal transmission within mother-pup pairs.  292 
 293 
Given the non-invasive nature of the study, it was not possible to assess tissue presence of 294 
PhHV-1 in live pups. However, the number of pups infected with PhHV-1 is likely to be 295 
substantially higher than the number of pups shedding the virus in nasal secretions. As a 296 
crude measure, if one assumes that stage II and stage V pups are of sufficiently different ages 297 
(average 4 days vs 18 days respectively) and that the duration of PhHV-1 nasal shedding does 298 
not exceed 14 days (7-19 days according to Goldstein et al. (2004)), shedding in stage V pups 299 
is likely to represent newly infected pups. The combined prevalence of PhHV-1 in stage II 300 
(39%) and stage V pups (66.7%) found in this study would support a very high risk of 301 
exposure of pups to the virus.  302 
 303 
The significantly higher prevalence of PhHV-1 among live, free-ranging pups on the tidal 304 
boulder beach site compared to the other two sites may be a consequence of regular 305 
displacement and subsequent crowding of these pups due to the twice daily high tides. This 306 
may lead to higher stress levels and also increased contact between pups and other adult 307 
seals. The very high prevalence of PhHV-1 found in pups dying at the rehabilitation centre 308 
(88.9%) may result from stress-induced viral replication and/or horizontal transmission of 309 
virus within individuals at the rehabilitation centre, such as that described previously in 310 
harbour seals (Goldstein et al. 2004, Himworth et al. 2010). The role of stress in the spread 311 
and pathogenesis of PhHV-1 warrants further investigation as the comparable prevalence of 312 
PhHV-1 in dead (56.2%) and live pups on the IOM (57.8%) does not support this. 313 
 314 
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The pathogenicity of PhHV-1 is poorly understood but the significant statistical correlation 315 
with hepatic necrosis, thymic atrophy and mouth ulcers found in this study may point to a 316 
similar pathogenesis to that seen in harbour seals (Borst et al. 1986, Goldstein et al. 2005, 317 
Himworth et al. 2010). This suggests that, even though grey seal pups have been shown to be 318 
less affected by this virus than the sympatric harbour seal (Martina et al. 2002), PhHV-1 may 319 
be a key component contributing to neonatal mortality both in the wild and in rehabilitation 320 
facilities. The key question of what causes the transition between PhHV-1 shedding and 321 
development of systemic disease in any seal species remains to be elucidated. Host factors 322 
such as immunosuppression or age at initial challenge, both factors known to affect the 323 
progression and outcome of FeHV1 in cats (Gaskell & Willoughby 1999), are likely to play a 324 
part in PhHV-1 pathogenesis and should be investigated further.  325 
 326 
The study also demonstrated that nasal shedding of PhHV-1 in yearling grey seals (27.8%) is 327 
most likely due to stress-induced recrudescence. Post-weaning to yearling grey seals undergo 328 
dramatic physiological changes including a switch in body composition from 13% to 20% 329 
protein at the expense of fat, which decreases from 40% to 12% body weight (Hall & 330 
McConnell 2007). A plausible hypothesis may be that there is some form of energetic trade-331 
off between resources for immunity and protein deposition, possibly compounded by the 332 
stress of returning to the breeding colony, which leads to this viral reactivation. The initial 333 
source of exposure of pups to PhHV-1 is unknown but extrapolation from other species and 334 
other neonatal alpha herpesviruses would suggest that both perinatal transmission from 335 
maternal vaginal secretions and horizontal pup to pup transmission may be involved. 336 
Pregnancy associated immuno-suppression has been previously demonstrated in grey seals 337 
(King et al. 1994) and the periparturient drop in immunity is a recognised trigger for 338 
transmission of parasites and viruses in numerous domestic animal species (Xiao et al. 1994, 339 
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Waller et al. 2004, Cattadori et al. 2005). As a result, Goldstein et al. (2004) speculated that 340 
in harbour seals, cows may be the source of infection through periparturient recrudescence of 341 
PhHV-1 excreted in nasal and vaginal secretions. To investigate this further in grey seals, 342 
nasal swabs and vaginal swabs should be taken from adult females immediately before and 343 
after pupping and from adult females out-with the breeding season. If PhHV-1 shedding is 344 
linked to stress, monitoring nasal viral titres could be used as an indicator of welfare/stress in 345 
seals in rehabilitation centres, informing indirectly on the effects of various husbandry 346 
practices. Rehabilitation centres would also provide an accessible system in which to study 347 
PhHV-1 transmission and pathogenesis in grey seal pups as has been performed previously in 348 
harbour seals (Goldstein et al. 2004, 2005).  349 
 350 
To help further elucidate the pathogenesis and tropism of this virus, the quantitation of virus 351 
load or transcription levels of RNA in individual tissues would be worthwhile. Similarly, 352 
localisation of the virus within lesions would be of use and given the absence of a suitable 353 
immunohistochemical method, development of an in-situ hybridisation probe to localise the 354 
pathogen would be justified. 355 
 356 
This work focused only on a single breeding season and a single colony, therefore care 357 
should be taken in extrapolating these findings to successive seasons and other colonies. 358 
Replication of this study over several seasons or after regular intervals would determine if 359 
these findings are typical for grey seal breeding colonies. However, the high prevalence of 360 
PhHV-1in the grey seal pups suggests a widespread exposure to the virus at birth, similar to 361 
that seen with other alpha herpesviruses.  362 
  363 
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Table and figure titles 364 
 365 
Table 1 Prevalence of PhHV-1. Number of positive animals (%: percentage of each group). 366 
 367 
Figure 1 PhHV-1 status of stranded dead and free-ranging dead grey seal pups presenting 368 
with differing degrees of thymic atrophy; Bars represent 95% confidence interval; 369 
Significance brackets represent result of generalised linear model comparing prevalence of 370 
PhHV-1 within groups of pups presenting each degree of thymic atrophy 371 
 372 
Supplementary tables 373 
 374 
Table S 1 Categorical risk factors, using univariate analysis, for detecting Phocid herpesvirus 375 
1 from nasal swabs from grey seals; (n=: group size; OR: odds ratio; 95% CI: 95% 376 
confidence interval; Inf: Infinity; Sign: Statistical significance of results; NS: non-significant; 377 
*: p<0.05; **: p<0.01; ***: p<0.001).  378 
 379 
Table S 2 Multivariate logistic regression analysis for PhHV-1 PCR of nasal swabs in live 380 
free-ranging grey seal pups. S.E. of coef: Standard error of coefficient; OR: odds ratio; 95% 381 
CI: 95% confidence interval. 382 
 383 
Table S 3 Multivariate logistic regression analysis for PhHV-1 PCR of nasal swabs in live 384 
free-ranging and stranded grey seal pups. S.E. of coef: Standard error of coefficient; OR: 385 
odds ratio; 95% CI: 95% confidence interval. 386 
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Table S 4 Odds ratio of finding lesions in pups with a positive PhHV-1 PCR status. (OR: 387 
odds ratio; 95% CI: 95% confidence interval; Inf: Infinity; Sign: Statistical significance of 388 
results; NS: non-significant; *: p<0.05; **: p<0.01; ***: p<0.001). 389 
 390 
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Table 1 Prevalence of PhHV-1. Number of positive animals (%: percentage of each group). 474 
Pathogen 
Stranded  
Live 
Stranded 
Dead 
Colony  
Live 
Colony 
Dead 
Colony 
Yearlings 
PhHV-1 Nasal 
swab 
18/29  
(62%) 
8/9  
(89%) 
52/90 
(58%) 
27/48 
(56%) 
5/18  
(28%) 
      
PhHV-1 Pooled 
tissue samples 
 6/9  
(67%) 
 26/48 
(54%) 
 
 
    
 475 
Figure 1: 476 
 477 
 478 
 479 
0 Minimal Mild Moderate to Severe
Degree of thymic atrophy
Pe
rc
e
n
t p
up
s 
of
 e
ac
h 
Ph
HV
1 
st
at
us
0
20
40
60
80
10
0
* 0.04
* 0.03
*** <0.001
PhHV1 Negative
PhHV1 Positive
hHV1 Negative
PhHV1 Positive
 Table S 1 Categorical risk factors, using univariate analysis, for detecting Phocid herpesvirus 
1 from nasal swabs of grey seals; (n=: group size; OR: odds ratio; 95% CI: 95% confidence 
interval; Inf: Infinity; Sign: Statistical significance of results; NS: non-significant; *: p<0.05; 
**: p<0.01; ***: p<0.001). 
  Risk factor Group (n=) 
number 
(%) 
positive 
  OR 95% CI 
P-
value 
Sign.  
All seals 
         
Group 
Free-ranging - live 90 52 (57.8%) 
 
1.00 
   Free-ranging - Dead 50 27 (56.2%) 
 
0.94 0.46, 1.91 0.863 NS 
Stranded - Live 31 18 (62.1%) 
 
1.20 0.51, 2.82 0.683 NS 
Stranded – 
died/euthanised 9 8 (88.9%) 
 
5.85 0.7,48.73 0.103 NS 
Live free-ranging 
yearlings 19 5 (27.8%) 
 
0.28 0.06 0.86 0.025 * 
                  
Free-
ranging 
live and 
dead 
pups 
                  
Live/dead Dead 50 27 (56.2%) 
 
1.00 
   
 
Live 90 52 (57.8%) 
 
1.06 0.52, 2.16 0.863 NS 
         Sex Female 65 34 (52.3%) 
 
1 
   
 
Male 72 45 (62.5%) 
 
1.52 0.77, 3 0.228 NS 
Mass range 
(kg) 
<12 13 5 (38.5%) 
 
1 
    12-25 73 31 (42.5%) 
 
1.18 0.35, 3.96 0.787 NS 
 25-31 13 11 (84.6%) 
 
8.8 1.35, 57.43 0.02 * 
>31 39 39 (28.3%) 
 
7.31 1.83, 29.2 0.004 ** 
                  
Free-
ranging 
Live pups 
only 
                  
Time point Early 30 11 (36.7%) 
 
1.00 
   
 
Mid 30 20 (66.7%) 
 
3.45 1.19, 9.99 0.022 * 
 
Late 30 21 (70%) 
 
4.00 1.37, 11.84 0.011 * 
         
Sampling 
site  
Tidal boulder beach 30 22 (73.3%) 
 
1.00 
   Rocky pools 30 18 (60%) 
 
0.55 0.18, 1.62 0.276 NS 
Muddy grassy slope 30 12 (40%) 
 
0.24 0.08, 0.72 0.011 * 
         
Coat 
  
Stage II 41 16 (39%) 
 
1.00 
   Stage III 13 9 (69.2%) 
 
3.52 0.93, 13.35 0.065 NS 
Stage IV - Moult 27 21 (77.8%) 
 
5.47 1.81, 16.48 0.003 ** 
Stage V- Adult coat 9 6 (66.7%)   3.12 0.68, 14.31 0.142 NS 
         
Table S 2 Multivariate logistic regression analysis for PhHV-1 PCR of nasal swabs in live 
free-ranging grey seal pups. S.E. of coef: Standard error of coefficient; OR: odds ratio; 95% 
CI: 95% confidence interval.  
Variable 
 
Coefficient. S.E. of coef. 
Odds ratio 
(OR) 
95% CI of 
OR 
p-value 
Intercept 
 
-2.89 0.92 - - - 
       Mass Mass in kg 0.17 0.017 1.15 1.08,1.22 <0.001 
       
Site 
Tidal boulder 
beach 
- - 1 - - 
 
Rocky pools -1.75 0.72 0.55 0.18, 1.62 0.015 
  
Muddy grassy 
slope -2.22 0.71 0.24 0.08, 0.72 0.002 
Table S 3 Multivariate logistic regression analysis for PhHV-1 PCR of nasal swabs in live 
free-ranging and stranded grey seal pups. S.E. of coef: Standard error of coefficient; OR: 
odds ratio; 95% CI: 95% confidence interval.  
Variable  Coefficient S.E.of coef. 
Odds ratio 
(OR) 
95% CI of 
OR 
p-value 
Intercept  -3.107 0.797    
       
Mass Mass in kg 0.128 0.03 1.09 1.04,1.14 <0.001 
       
Colony 
Free-ranging 
pups - - 1 - - 
  Stranded pups 1.592 0.55 1.2 0.51, 2.82 0.003 
       
Table S 4 Odds ratio of finding lesions in pups with a positive PhHV-1 PCR status. (OR: 
odds ratio; 95% CI: 95% confidence interval; Inf: Infinity; Sign: Statistical significance of 
results; NS: non-significant; *: p<0.05; **: p<0.01; ***: p<0.001). 
Lesion 
PhHV-1 
status 
number 
(%) 
positive 
  OR 95% CI   
P-
value 
 Sign. 
 
        
Adrenal 
necrosis 
HV - 1 (5.9%)       
HV + 7 (16.7%)  3.20 0.36, 28.23  0.29 NS 
 
        
Hepatic 
necrosis 
HV - 1 (5.9%)       
HV + 20 (50%)  16.00 1.93, 132.39  0.01 * 
 
        
Multifocal 
hepatitis 
HV - 4 (23.5%)       
HV + 16 (38.1%)  2.00 0.55, 7.21  0.289 NS 
 
        
Thymic 
Atrophy 
HV - 4 (23.5%)       
HV + 31 (81.6%)  14.39 3.59, 57.71  <0.001 *** 
 
        
Buccal 
ulceration 
HV - 1 (5.9%)       
HV + 17 (40.5%)  10.88 1.32, 89.93  0.027 * 
 
        
Tongue 
ulceration 
HV - 3 (17.6%)       
HV + 11 (26.2%)  1.66 0.4, 6.88  0.488 NS 
 
        
Keratitis 
HV - 0 (0%)       
HV + 4 (9.5%)  33091159 0, Inf  0.995 NS 
 
        
Uveitis 
HV - 0 (0%)       
HV + 5 (12.5%)  44909430 0, Inf  0.995 NS 
 
        
Interstitial 
pneumonia 
HV - 7 (41.2%)       
HV + 22 (52.4%)  1.57 0.5,4.91  0.437 NS 
 
 
